Navigation Links
China-Biotics, Inc. Reports Second Quarter 2009 Financial Results
Date:11/11/2008

SHANGHAI, China, Nov. 11 /Xinhua-PRNewswire-FirstCall/ -- China-Biotics, Inc. (Nasdaq: CHBT) ("China-Biotics", "the Company"), a leading Chinese firm specializing in the manufacture, research, development, marketing and distribution of probiotics products, today announced its financial results for the second quarter of its 2009 fiscal year, ended September 30, 2008.

Second Quarter 2009 Highlights

-- Net sales increased 47.0% year-over-year to $11.5 million

-- Gross profit increased 43.1% year-over-year to $8.0 million

-- Gross margin was 69.9%

-- Net income was $4.5 million

-- Excluding a $1.9 million gain related to the change in fair value of

convertible notes, net income increased 30.4% year over year to $2.6

million

-- Diluted earnings per share was $0.13, compared to $0.11 the prior year

-- Opened 27 retail outlets during the quarter, bringing the total number

of outlets to 110 in 13 cities in China

-- Signed agreement with Henan Square Pharmaceutical Co., Ltd to supply

probiotics for its probiotics-based medicines

-- Began installing equipment for its new manufacturing facility in Qing

Pu Industrial Park in Shanghai

-- Began trading on the Nasdaq Global Market in October

Second Quarter 2009 Results

During the second quarter of the 2009 fiscal year, net sales increased 47.0% to $11.5 million from $7.8 million the prior year, as a result of growth in the sales volume of new products and increases in the sales price of selected products. Sales also benefited from an increase in the number of the Company's Shining retail outlets to 110 from 22 the prior year. New products, including Shining Essence Stomach
'/>"/>

SOURCE China-Biotics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. China-Biotics, Inc. Signs Intention Agreement to Supply Probiotics to Bright Dairy & Food Co., Ltd.
2. China-Biotics, Inc. Launches Shining Probiotics Protein Powder
3. China-Biotics, Inc. Receives Approval to Begin Construction on Large-Scale Manufacturing Facility
4. China-Biotics, Inc. Announces Conference Call to Discuss First Quarter FY 2008 Results
5. China-Biotics, Inc. Launches English / Chinese Corporate and Investor Relations Web Site
6. China-Biotics, Inc. Announces Rescheduling of Conference Call to Discuss Third Quarter 2008 Results
7. China-Biotics, Inc. Reports Third Quarter 2008 Financial Results
8. China-Biotics, Inc. Completes Foundation for Its New Plant
9. China-Biotics, Inc. to Present at Two Upcoming Investor Conferences
10. China-Biotics, Inc. to Supply Probiotics to Pharmaceutical Company
11. China-Biotics, Inc. Announces Conference Call to Discuss Fourth Quarter and Full Year 2008 Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...24 Sigma-Aldrich Corpora...SDAQ OMX conference on Tuesday, December 1st at 1:...rties may listen via live audio broadcast over the...m a a ldrich.com/ . Users can click the "Webc...ma-Aldrich: Sigma-Aldrich is a leading Life Scie...
(Date:11/24/2009)...YKJAVIK, Iceland, November 24 /PRNewswire-FirstCal...announced the approval of all of its,"first day" m...ct of Delaware,(the "Bankruptcy Court"). deCODE la...r Chapter 11 of the United States Bankruptcy Code ...ssued by the Bankruptcy Court allow the company to...
(Date:11/24/2009)...f., Nov. 24 NeurogesX, I...focused on developing and commercializing novel pa...ony DiTonno, President and Chief Executive Officer... Jaffray Health Care Conference, to be held Decemb...ork, New York. ,, Mr. DiTonno and Stephen Ghig...
(Date:11/24/2009)...RNewswire/ -- Blue Marble Energy Corp. announced t...pment Authority (OPDA) were recently awarded $2 mi...italization Board (CERB) in a private/public partn...ochemical biorefinery in Lincoln County, WA. ,...evelopment of our biorefinery and bring over 70 gr...
Breaking Biology Technology:deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2
...LE, Md., Sept. 18 Human Genome,Sciences, Inc. (Na...n at the,UBS Global Life Sciences Conference will ....com , (Logo: http://www.newscom.com/cgi-bin/prn...ciences, senior management team will present,a cor...1:30 am Eastern,Time., Investors interested in li...
... Sept. 18 More than 60 physicians credentialed,to...esbyterian Hospital of,Dallas were honored by D Ma...Institute for Surgery is one of the premier specia...tremendous honor to have so many of,our physicians...icians who,operate at TIS are undoubtedly some of ...
... CEO is featured speaker: "Case Study - Screening ...riday, September 26 at 11:30, CLEVELAND, Sept. 18...channel services and cell lines for drug-discovery...ssays and Cellular Targets,conference in San Diego...el,cell lines and services to provide drug-discove...
Other Biology Technology:Annual List of 'Best Doctors in Dallas' Showcases Texas Institute for Surgery Physicians 2ChanTest to Highlight the World's Largest Catalog of Ion Channel-Expressing Cell Lines and Discovery Services at Assays & Cellular Targets Conference, Booth 11 2
(Date:11/26/2009)...ad researchers have developed a new type of geneti...s and proteins used by pathogens, according to the...ures genes are present in two copies: one inherite...activation by mutation is therefore inefficient be...y usually remains active and takes over. , In ye...
(Date:11/26/2009)...ureus ) and other drug-resistant bacteria could fa...e devices have been developed to offer safe, quick...wo prototype devices have been developed: one for ... and feet) in hospitals and public spaces where ba...oot bacteria-killing agents into infested chronic ...
(Date:11/25/2009)...ay be used to boost resistance to, or slow, the de...edicine researchers report in a study published in..., Parkinson,s disease is caused by a degeneratio...nown as the substantia nigra, which is responsible...opamine in late-stage Parkinson,s causes symptoms ...
Breaking Biology News(10 mins):Knockouts in human cells point to pathogenic targets 2Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Hormone ghrelin can boost resistance to Parkinson's disease 2Fertility Drug Shows Potential Against Hot Flashes 57432 1Fertility Drug Shows Potential Against Hot Flashes 57432 2Fertility Drug Shows Potential Against Hot Flashes 57432 3More Chest Compressions During CPR Improves Survival Odds 57430 1More Chest Compressions During CPR Improves Survival Odds 57430 2Cases of liver cancer reduced in a younger population vaccinated for HBV 57428 1
... The St. Johns River Management District (SJRWMD) ...two-year, $300,000 project to obtain additional da...kton) that inhabit the St. Johns River. The study ...s public concern regarding the cumulative impact o...ver. , One measure of the rivers current and fut...
... Shape matters, even in hearing. , Specifically, i...ped organ in the inner ear that converts sound wav...hich proves to be surprisingly important. , A stud... the National Academy of Sciences establishes a di...ow-frequency hearing limit of more than a dozen di...
... An immune cell known as a neutrophil releases a p... liver without targeting insulin, researchers have...l, produce special immune proteins called defensin...els. During bacterial infection, defensin producti...ly results in hypoglycemia. In addition, many pati...
Other Biology News:Grant to fund answers about St. Johns River 2Study links low-frequency hearing to shape of the cochlea 2Study links low-frequency hearing to shape of the cochlea 3Study links low-frequency hearing to shape of the cochlea 4
Anti-p38 MAP Kinase gamma Antibody, Unconjugated from Cell Signaling Technology
Chicken Anti-HAGH Polyclonal Antibody, Unconjugated from Abcam
Anti-FLIPgamma / delta (CT) Antibody, Unconjugated from QED Bioscience Inc.
Mouse Anti-14-3-3 Binding Motif, phospho (Ser) Monoclonal Antibody, Unconjugated, Clone 4E2 from Cell Signaling Technology
Biology Products: